Evidence map›Paper›PMID 31760228›Full record

ArticleThe Journal of nutritional biochemistry2020

α-Linolenic acid-enriched butter attenuated high fat diet-induced insulin resistance and inflammation by promoting bioconversion of n-3 PUFA and subsequent oxylipin formation.

Rong Fan, Judy Kim, Mikyoung You, David Giraud, Ashley M Toney, Seung-Ho Shin, So-Youn Kim, Kamil Borkowski, John W Newman, Soonkyu Chung

Open access · greenAbstract read
In one paragraph

Article in The Journal of nutritional biochemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Oxylipin secretion by human CD3Frontiers in immunology · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Rong FanDepartment of Nutrition and Health Sciences, University of Nebraska, Lincoln, NE.
Judy KimDepartment of Nutrition and Health Sciences, University of Nebraska, Lincoln, NE.
Mikyoung YouDepartment of Nutrition and Health Sciences, University of Nebraska, Lincoln, NE.
David GiraudDepartment of Nutrition and Health Sciences, University of Nebraska, Lincoln, NE.
Ashley M ToneyDepartment of Nutrition and Health Sciences, University of Nebraska, Lincoln, NE.
Seung-Ho ShinSunseo Omega Inc, University of Nebraska Innovation Campus, Lincoln, NE.
So-Youn KimOlson Center for Women's Health, Department of Obstetrics and Gynecology, and Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE.
Kamil BorkowskiWest Coast Metabolomics Center, Genome Center, University of California Davis, Davis, CA.
John W NewmanWest Coast Metabolomics Center, Genome Center, University of California Davis, Davis, CA; Obesity and Metabolism Research Unit, USDA-ARS-WHNRC, Davis, CA.
Soonkyu ChungDepartment of Nutrition and Health Sciences, University of Nebraska, Lincoln, NE. Electronic address: schung4@unl.edu.
University of Nebraska–Lincoln · USUniversity of California, Davis · USUniversity of Nebraska Medical Center · US

Funding

West Coast Central Comprehensive Metabolomics Resource Core (WC3MRC)U24DK097154 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIEHN, OLIVER · 2012 to 2017
$9.9M
Epigenetic Regulation of fetal BAT Development via Maternal N-3 PUFA intakeR21HD094273 · NICHD · UNIVERSITY OF NEBRASKA LINCOLN · PI CHUNG, SOONKYU · 2019 to 2020
$416k
NICHD NIH HHS R21 HD094273NIDDK NIH HHS U24 DK097154
6 · The paper itself

Abstract

α-Linolenic acid (ALA) is an essential fatty acid and the precursor for long-chain n-3 PUFA. However, biosynthesis of n-3 PUFA is limited in a Western diet likely due to an overabundance of n-6 PUFA. We hypothesized that dietary reduction of n-6/n-3 PUFA ratio is sufficient to promote the biosynthesis of long-chain n-3 PUFA, leading to an attenuation of high fat (HF) diet-induced obesity and inflammation. C57BL/6 J mice were fed a HF diet from ALA-enriched butter (n3Bu, n-6/n-3=1) in comparison with isocaloric HF diets from either conventional butter lacking both ALA and LA (Bu, n-6/n-3=6), or margarine containing a similar amount of ALA and abundant LA (Ma, n-6/n-3=6). Targeted lipidomic analyses revealed that n3Bu feeding promoted the bioconversion of long-chain n-3 PUFA and their oxygenated metabolites (oxylipins) derived from ALA and EPA. The n3Bu supplementation attenuated hepatic TG accumulation and adipose tissue inflammation, resulting in improved insulin sensitivity. Decreased inflammation by n3Bu feeding was attributed to the suppression of NF-κB activation and M1 macrophage polarization. Collectively, our work suggests that dietary reduction of the n-6/n-3 PUFA ratio, as well as total n-3 PUFA consumed, is a crucial determinant that facilitates n-3 PUFA biosynthesis and subsequent lipidomic modifications, thereby conferring metabolic benefits against obesity-induced inflammation and insulin resistance.

Indexed as

Diet, High-FatInsulin Resistancealpha-Linolenic AcidAnimalsFatty AcidsFatty Acids, Omega-3Fatty Acids, UnsaturatedGlucose Tolerance TestInflammationInsulinLipidomicsLiverMaleMiceMice, Inbred C57BLOxylipinsalpha-Linolenic AcidFatty AcidsFatty Acids, Omega-3Fatty Acids, UnsaturatedInsulinOxylipinsALAButterInsulin ResistanceMacrophage PolarizationN-6/N-3 PUFA RatioOxylipins

Identifiers

PMID31760228
PMCPMC6995772
OpenAlexW2987246076

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.